Gene Therapy Effective for Severe Combined Immunodeficiency
Gene Therapy Effective for Severe Combined Immunodeficiency
Researchers report they’ve found a way to restore immune function in infants with one form of “bubble boy disease.”
Gene Therapy Effective for Severe Combined Immunodeficiency
Gene Therapy Effective for Severe Combined Immunodeficiency

Researchers report they’ve found a way to restore immune function in infants with one form of “bubble boy disease.”

Researchers report they’ve found a way to restore immune function in infants with one form of “bubble boy disease.”

T cells
Tuberculosis Can Emerge After Cancer Immunotherapy
Tuberculosis Can Emerge After Cancer Immunotherapy
Ashley Yeager | Apr 1, 2019
At least a handful of patients have developed active TB after receiving cancer treatment designed to boost the immune system’s antitumor response.
Salt Could Play a Role in Allergies
Salt Could Play a Role in Allergies
Abby Olena | Feb 20, 2019
High salt concentrations are present in the affected skin of people with atopic dermatitis and promote the differentiation of the T helper cells involved in the development of allergic diseases.
Infographic: The Omentum’s Role in Health and Disease
Infographic: The Omentum’s Role in Health and Disease
Selene Meza-Perez, Troy D. Randall | Oct 1, 2018
Belly fat helps fight infection, but is also a common site of metastasis.
Electric Shock Allows for CRISPR Gene Editing Without a Viral Vector
Electric Shock Allows for CRISPR Gene Editing Without a Viral Vector
Ashley Yeager | Jul 12, 2018
Brief electroporation appears to make T cells more receptive to new genetic material, which could speed the development of immunotherapies.
New Ovarian Cancer Vaccine Shows Promise
New Ovarian Cancer Vaccine Shows Promise
Catherine Offord | Apr 12, 2018
A preliminary clinical trial finds that the personalized therapy improves survival rates and has no severe side-effects.
High-Throughput Epigenetics Analyses
High-Throughput Epigenetics Analyses
Jyoti Madhusoodanan | Jan 1, 2018
Emerging technologies help researchers draw mechanistic links between metabolism and epigenetic modification of DNA.
New CAR T-Cell Therapy Shows Promise in Trial for Leukemia
New CAR T-Cell Therapy Shows Promise in Trial for Leukemia
Katarina Zimmer | Nov 21, 2017
The immunotherapy, which targets CD22 on cancer cells rather than CD19, might prove useful in patients for whom previous T-cell treatments were unsuccessful. 
First CAR T-Cell Therapy Approved in U.S.
First CAR T-Cell Therapy Approved in U.S.
Shawna Williams | Aug 30, 2017
The genetically modified blood cells will be used for patients with a type of acute lymphoblastic leukemia, when other treatments fail.
Immunotherapy Promising for Diabetes: Study
Immunotherapy Promising for Diabetes: Study
Aggie Mika | Aug 9, 2017
A small clinical trial demonstrates that peptide immunotherapy can halt the progression of early-stage type 1 diabetes.